Search research articles
Contact Us
Filters
Showing results (1-10 of 59) with videos related to
Page
of 6
Sort By:
Current Treatment Options in Oncology
|
April 6, 2013
Systemic therapy for inoperable and metastatic basal cell cancer
Leslie A Fecher
Otolaryngologic Clinics of North America
|
February 19, 2021
The Role of Systemic Therapy in Advanced Cutaneous Melanoma of the Head and Neck
Melissa A Wilson, Leslie A Fecher
Biologics : Targets & Therapy
|
November 26, 2015
Advanced basal cell carcinoma, the hedgehog pathway, and treatment options - role of smoothened inhibitors
Leslie A Fecher, William H Sharfman
Journal of the National Comprehensive Cancer Network : JNCCN
|
April 30, 2009
Where are we with adjuvant therapy of stage III and IV melanoma in 2009?
Leslie A Fecher, Keith T Flaherty
Pigment Cell & Melanoma Research
|
August 20, 2008
Effectively targeting BRAF in melanoma: a formidable challenge
Leslie A Fecher, Ravi Amaravadi, Lynn M Schuchter
Current Opinion in Oncology
|
February 28, 2008
The MAPK pathway in melanoma
Leslie A Fecher, Ravi K Amaravadi, Keith T Flaherty
Immunotherapy
|
April 13, 2022
Successful use of secukinumab in two melanoma patients with immune checkpoint inhibitor-induced inflammatory arthropathy
Vincent T Ma, Christopher D Lao, Leslie A Fecher, et al.
Seminars in Liver Disease
|
October 26, 2018
Liver Toxicity with Cancer Checkpoint Inhibitor Therapy
Brian A Nadeau, Leslie A Fecher, Scott R Owens, et al.
Hematology/Oncology Clinics of North America
|
May 26, 2009
Drug targeting of oncogenic pathways in melanoma
Leslie A Fecher, Ravi K Amaravadi, Lynn M Schuchter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 20, 2007
Toward a molecular classification of melanoma
Leslie A Fecher, Staci D Cummings, Megan J Keefe, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 59) with videos related to
Sort By:
Page
of 6
Current Treatment Options in Oncology
|
April 6, 2013
Systemic therapy for inoperable and metastatic basal cell cancer
Leslie A Fecher
Otolaryngologic Clinics of North America
|
February 19, 2021
The Role of Systemic Therapy in Advanced Cutaneous Melanoma of the Head and Neck
Melissa A Wilson, Leslie A Fecher
Biologics : Targets & Therapy
|
November 26, 2015
Advanced basal cell carcinoma, the hedgehog pathway, and treatment options - role of smoothened inhibitors
Leslie A Fecher, William H Sharfman
Journal of the National Comprehensive Cancer Network : JNCCN
|
April 30, 2009
Where are we with adjuvant therapy of stage III and IV melanoma in 2009?
Leslie A Fecher, Keith T Flaherty
Pigment Cell & Melanoma Research
|
August 20, 2008
Effectively targeting BRAF in melanoma: a formidable challenge
Leslie A Fecher, Ravi Amaravadi, Lynn M Schuchter
Current Opinion in Oncology
|
February 28, 2008
The MAPK pathway in melanoma
Leslie A Fecher, Ravi K Amaravadi, Keith T Flaherty
Immunotherapy
|
April 13, 2022
Successful use of secukinumab in two melanoma patients with immune checkpoint inhibitor-induced inflammatory arthropathy
Vincent T Ma, Christopher D Lao, Leslie A Fecher, et al.
Seminars in Liver Disease
|
October 26, 2018
Liver Toxicity with Cancer Checkpoint Inhibitor Therapy
Brian A Nadeau, Leslie A Fecher, Scott R Owens, et al.
Hematology/Oncology Clinics of North America
|
May 26, 2009
Drug targeting of oncogenic pathways in melanoma
Leslie A Fecher, Ravi K Amaravadi, Lynn M Schuchter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 20, 2007
Toward a molecular classification of melanoma
Leslie A Fecher, Staci D Cummings, Megan J Keefe, et al.
Page
of 6